Sight Sciences (SGHT) Stock: Buy, Sell, or Hold?
SGHT - Sight Sciences, Inc. Common Stock
$8.90
0.20 (2.24%)
â˛
5d:
+1.08%
30d:
+4.65%
90d:
+81.16%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 05, 2026
13d
Get Alerted When SGHT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: SGHT is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: SGHT is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: SGHT is currently trading at $8.89, which is considered slightly high relative to its 30-day fair value range of $8.24 to $8.98.
Technical Outlook: Technically, SGHT is in a strong uptrend. The price is approaching resistance at $9.04. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SGHT scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $10.17 (+16.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SGHT is in a strong uptrend. The price is approaching resistance at $9.04. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SGHT scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $10.17 (+16.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$8.24 -
$8.98
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.1%
All Signals
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (33/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($10.17)
- WARNING: Composite score 48/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$8.24 -
$8.98
Current vs Trading Range
SLIGHTLY HIGH
Expected Move (7 Days)
Âą$0.88
(9.8%)
Support & Resistance Levels
Support Level
$7.84
Resistance Level
$9.05
Current Trend
Strong Uptrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-21.74
Wall Street Target
$10.17
(+16.9%)
Revenue Growth (YoY)
19.5%
Profit Margin
-35.7%
Share & Embed Analysis
Last updated: October 22, 2026 12:56 PM ET
Data refreshes hourly during market hours. Next update: 1:56 PM
Data refreshes hourly during market hours. Next update: 1:56 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SGHT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
31 analysts |
$59 | 49 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
29 analysts |
$363 | 32 SELL |
|
MDT
Medtronic PLC |
BUY
29 analysts |
$105 | 44 HOLD |
|
AXGN
Axogen Inc |
STRONG BUY
12 analysts |
$54 | 73 BUY |
|
IRTC
iRhythm Technologies Inc |
STRONG BUY
15 analysts |
$171 | 48 HOLD |
